Age-Specific Distribution and Factors Associated with High-Risk HPV Infection and Cervical Lesions Among HIV-Positive and -Negative Women in Maputo, Mozambique: Findings from the HPV-ISI Study (2021–2022)

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background/Objective: High-risk Human papillomavirus (hrHPV) is the leading cause of premalignant lesions and cervical cancer (CC), affecting disproportionally women living with HIV. Mozambique is among the countries with a heavy triple-burden of HIV, hrHPV infections and CC which accounts for more than 5300 new cases and 3800 deaths each year. In this study, we assessed the age-specific distribution and factors associated with hrHPV and cervical lesions among HIV-positive and -negative women from HPV-ISI (HPV Innovative Screening Initiative) study in Maputo, Mozambique. Methods: This cross-sectional study included 1,248 non-pregnant women aged ≥18 years who attended CC screening at the DREAM Sant’Egídio Health Center between July 2021 and April 2022. Screening involved visual inspection with acetic acid (VIA) and high-risk HPV DNA testing. Sociodemographic, lifestyle, and reproductive data were collected through a routine questionnaire. Logistic regression assessed associations between risk factors and hrHPV infection or cervical lesions. Age-specific hrHPV prevalence, partial HPV16/18 genotyping, and abnormal cytology rates were further analyzed by HIV status. Results: The mean age was 43.0±8.6 years. The hrHPV prevalence was 28%, higher in HIV-positive (46.8%) than HIV-negative (23.8%) women. Non-16/18 hrHPV types predominated across all ages. VIA positivity was 11.1%, mostly involving <75% cervical area, and was more frequent in younger (30–45 years) and HIV-positive women. Older age (OR 0.98, 95% CI 0.97–1.00, p=0.017) and higher parity (≥3 vs nulliparous: OR 0.58, 95% CI 0.36–0.94, p=0.029) showed protective effects against hrHPV infection. Contraceptive use (OR 1.65, 95% CI 1.15–2.38, p=0.007) and partially/non-visible SCJ (OR 2.88, 95% CI 1.74–4.79, p<0.001) were associated with VIA positivity. Conclusions: hrHPV infection and cervical lesions were more frequent in younger and HIV-positive women, highlighting the need for strengthened targeted screening within HIV care services in Mozambique.

Article activity feed